首页 | 本学科首页   官方微博 | 高级检索  
     


The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma
Authors:Mitrovic Zdravko  Bast Martin  Bierman Philip J  Bociek Robert G  Vose Julie M  Chan Wing C  Armitage James O
Affiliation:1. Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA;2. School of Medicine, University of Zagreb, Zagreb, Croatia;3. Department of Internal Medicine, Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
E‐mail: joarmita@unmc.edu
Abstract:
Keywords:non‐Hodgkin lymphoma  diffuse large B‐cell lymphoma  secondary central nervous system lymphoma  rituximab  relapse
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号